Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)

3. november 2026 opdateret af: Deborah Ejem, University of Alabama at Birmingham

Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)

The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.

Studieoversigt

Status

Ikke rekrutterer endnu

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

44

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Alexis M Johnson, B.S.
  • Telefonnummer: 205-975-1864
  • E-mail: amjohns2@uab.edu

Undersøgelse Kontakt Backup

  • Navn: Deborah B Ejem, Ph.D.
  • Telefonnummer: 205-996-1671
  • E-mail: tejem@uab.edu

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35233
        • The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
        • Kontakt:
        • Kontakt:
          • Deborah B Ejem, Ph.D.
          • Telefonnummer: 205-996-1671
          • E-mail: tejem@uab.edu

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria for Patients:

  1. Identifies as African American or White/Caucasian
  2. Is 65 years of age or older
  3. Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has a family caregiver that meets the eligibility requirements
  7. Has reliable telephone access

Inclusion Criteria for Caregivers:

  1. Identifies as African American or White/Caucasian
  2. Is 18 years of age or older
  3. A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has reliable telephone access

Exclusion Criteria for Patients:

  1. Has a documented diagnosis of dementia
  2. Is unable to understand the study and provide informed consent
  3. Resides in a nursing home or assisted living facility

Exclusion Criteria for Caregivers:

  1. Is unable to understand the study and provide informed consent
  2. Is unable to communicate with research staff
  3. Is unable to participate in the dyadic MyHP-South session and required assessments

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: MyHP-South Users

Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting.

Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient System Usability Scale (SUS)
Tidsramme: At the MyHP-South session, within 14 days after baseline.

Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

At the MyHP-South session, within 14 days after baseline.
Acceptability Interview
Tidsramme: At the MyHP-South session, within 14 days after baseline.

Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended.

At the MyHP-South session, within 14 days after baseline.
Recruitment Feasibility
Tidsramme: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).

Indicated by the number and proportion of eligible patient-caregiver dyads who enroll.

From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
Retention and Completion Feasibility
Tidsramme: From baseline through 12 weeks after the MyHP-South session.

Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments.

From baseline through 12 weeks after the MyHP-South session.
Caregiver System Usability Scale (SUS)
Tidsramme: Immediately after the MyHP-South session, during the same study visit.

Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

Immediately after the MyHP-South session, during the same study visit.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
CollaboRATE Scale Score
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage.

At baseline and 12 weeks after the MyHP-South session.
Treatment Burden Questionnaire (TBQ) Score
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score.

At baseline and 12 weeks after the MyHP-South session.
Patient Shared Care Instrument Score
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

At baseline and 12 weeks after the MyHP-South session.
Bakas Caregiver Outcomes Scale (BCOS)
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best.

At baseline and 12 weeks after the MyHP-South session.
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score.

At baseline and 12 weeks after the MyHP-South session.
Caregiver Shared Care Instrument Score
Tidsramme: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

At baseline and 12 weeks after the MyHP-South session.

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Timing Log for MyHP-South Session
Tidsramme: At the MyHP-South session, within 14 days after baseline.

Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility.

At the MyHP-South session, within 14 days after baseline.
Clinician Feedback Survey
Tidsramme: Within 6 months after the completion of the MyHP-South session.

Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting.

Within 6 months after the completion of the MyHP-South session.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Deborah B Ejem, Ph.D., University of Alabama at Birmingham

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. januar 2027

Primær færdiggørelse (Anslået)

31. december 2027

Studieafslutning (Anslået)

31. december 2027

Datoer for studieregistrering

Først indsendt

29. oktober 2026

Først indsendt, der opfyldte QC-kriterier

3. november 2026

Først opslået (Faktiske)

9. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. november 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • IRB-300016725
  • U54AG093230 (U.S. NIH-bevilling/kontrakt)
  • 606877 (Anden identifikator: ASSIST Study ID)
  • DGCG-11797 (Anden identifikator: NIA CROMS Study ID)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner